Similar articles

• The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.

  Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P. Bayrak A, et al. Arch Gynecol Obstet. 2006 Aug;274(5):289-96. doi: 10.1007/s00404-006-0187-2. Epub 2006 Jun 30. Arch Gynecol Obstet. 2006. PMID: 16810536
• Comparative cardiovascular effects of different progestins in menopause.

  Rosano GM, Fini M. Rosano GM, et al. Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Int J Fertil Womens Med. 2001. PMID: 11720197 Review.
• [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism].

  García L, Hernández I, Cervera Aguilar R, Ayala AR. García L, et al. Ginecol Obstet Mex. 2001 Sep;69:351-4. Ginecol Obstet Mex. 2001. PMID: 11816532 Clinical Trial. Spanish.
• Transdermal hormone replacement therapy, serum lipids and lipoproteins.

  Crook D, Stevenson JC. Crook D, et al. Br J Clin Pract Suppl. 1996 Sep;86:17-21. Br J Clin Pract Suppl. 1996. PMID: 8995006 Review. No abstract available.
• Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.

  Hodis HN, Mack WJ, Lobo RA. Hodis HN, et al. Circulation. 2003 Jul 8;108(1):e5; author reply e5. doi: 10.1161/01.CIR.0000080080.76333.38. Circulation. 2003. PMID: 12847059 No abstract available.